Pharma
Torrent Pharmaceuticals Ltd
TORNTPHARM · NSE · INE685A01028Thursday, 10 Sept 202612:16 pm
Market Cap₹1,88,341 Cr
P/E79.1
P/B20.0
EPS₹62.61
Div Yield0.8%
ROE26.8%
ROCE8.1%
ROE26.8%
1Y Return+25.69%
Avg. Volume0.4M
Price Chart
52-Week Range
About
Torrent Pharmaceuticals Ltd is a Pharma company listed on NSE.
Technicals
Free account
Register freeTechnicals
Create a free account to view momentum, moving averages, and delivery signals.
Quant
Premium
UpgradeQuant metrics
Upgrade to view volatility, drawdown, factor, and risk metrics.
Key Ratios
Market Cap₹1,88,341 Cr
Current Price₹4,951.6
52W High / Low₹5,250 / ₹3,480.6
Stock P/E79.1
Price to Book20.0
EPS (TTM)₹62.61
Dividend Yield0.8%
ROE26.8%
1Y Return+25.69%
Day Change+0.40%
Profit & Loss
| Period | TTM | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ₹15,723 Cr | ₹13,980 Cr | ₹11,516 Cr | ||||||||||
| Expenses | ₹10,532 Cr | ₹9,421 Cr | ₹7,795 Cr | ||||||||||
| Operating Profit | ₹5,191 Cr | ₹4,558 Cr | ₹3,721 Cr | ||||||||||
| OPM % | 33.0% | 33.0% | 32.0% | ||||||||||
| Other Income | ₹-179 Cr | ₹-182 Cr | ₹-1 Cr | ||||||||||
| Depreciation | ₹1,511 Cr | ₹1,119 Cr | ₹795 Cr | ||||||||||
| Interest | ₹634 Cr | ₹385 Cr | ₹252 Cr | ||||||||||
| Profit Before Tax | ₹2,867 Cr | ₹2,872 Cr | ₹2,673 Cr | ||||||||||
| Tax | ₹711 Cr | ₹734 Cr | ₹762 Cr | ||||||||||
| Net Profit | ₹2,156 Cr | ₹2,138 Cr | ₹1,911 Cr | ||||||||||
| EPS (₹) | 63.7 | 63.9 | 56.5 | ||||||||||
| Dividend Payout % | — | 59% | 57% |
Financial history locked
Register freeRegister free to see 10 more years.
Quarterly Results
| Quarter | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ₹4,921 Cr | ₹4,197 Cr | ₹3,303 Cr | ₹3,302 Cr | |||||||||
| Expenses | ₹3,257 Cr | ₹2,841 Cr | ₹2,215 Cr | ₹2,219 Cr | |||||||||
| Operating Profit | ₹1,664 Cr | ₹1,356 Cr | ₹1,088 Cr | ₹1,083 Cr | |||||||||
| OPM % | 34.0% | 32.0% | 33.0% | 33.0% | |||||||||
| Depreciation | ₹593 Cr | ₹508 Cr | ₹206 Cr | ₹204 Cr | |||||||||
| Interest | ₹305 Cr | ₹236 Cr | ₹45 Cr | ₹48 Cr | |||||||||
| Net Profit | ₹566 Cr | ₹364 Cr | ₹635 Cr | ₹591 Cr | |||||||||
| EPS (₹) | 16.7 | 10.8 | 18.8 | 17.5 |
Quarterly history locked
Register freeRegister free to see 9 more quarters.
Balance Sheet
| Period | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Capital | ₹169 Cr | ₹169 Cr | ₹169 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reserves | ₹8,219 Cr | ₹7,421 Cr | ₹6,687 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Borrowings | ₹15,026 Cr | ₹3,202 Cr | ₹4,022 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Liabilities | ₹20,200 Cr | ₹3,604 Cr | ₹3,627 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | ₹43,614 Cr | ₹14,396 Cr | ₹14,505 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Assets | ₹33,191 Cr | ₹7,947 Cr | ₹8,138 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | ₹948 Cr | ₹156 Cr | ₹173 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Equivalents | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets | ₹8,833 Cr | ₹5,815 Cr | ₹5,834 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Assets | ₹43,614 Cr | ₹14,396 Cr | ₹14,505 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance sheet history locked
Register freeRegister free to see 10 more years.
Cash Flow
| Period | Operating | Investing | Financing | Net Cash Flow |
|---|---|---|---|---|
| FY26 | ₹3,023 Cr | ₹-12,630 Cr | ₹10,151 Cr | ₹544 Cr |
| FY25 | ₹2,585 Cr | ₹-549 Cr | ₹-2,298 Cr | ₹-262 Cr |
| FY24 | ₹3,266 Cr | ₹-160 Cr | ₹-2,780 Cr | ₹327 Cr |
| FY23 | ||||
| FY22 | ||||
| FY21 | ||||
| FY20 | ||||
| FY19 | ||||
| FY18 | ||||
| FY17 | ||||
| FY16 | ||||
| FY15 |
Cash flow history locked
Register freeRegister free to see 10 more years.
Peer Comparison
| Company | M.Cap | P/E | ROE | 1Y Return |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | — | — | +14.78% | +7.18% |
| Dr Reddys Laboratories Ltd | — | — | +8.84% | -3.74% |
| Cipla Ltd | — | — | +11.77% | -5.50% |
| Apollo Hospitals Enterprise Ltd | — | — | +22.64% | +23.01% |
| Divis Laboratories Ltd | ₹2,50,065 Cr | 83.9 | +16.5% | +46.29% |
Mutual Fund Holdings
Free account
Register freeMutual fund holdings
Create a free account to see institutional ownership snapshots.
Bulk & Block Deals
Free account
Register freeBulk & block deals
Create a free account to view recent institutional deal activity.
Analyst Estimates
Free account
Register freeAnalyst estimates
Create a free account to view analyst estimate summaries.
Latest News
2026-09-10Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE Filing2026-07-30Torrent Pharmaceuticals Ltd (BOM:500420) (Q1 2027) Earnings Call Highlights: Record Revenue ...GuruFocus.com2026-07-29Earnings To Watch: Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) Q1 2027 -- GF Value Sees 14% UpsideGuruFocus.com2026-06-09[Latest] Global Generic Drug Market Size/Share Worth USD 926.54 Billion by 2034 at a 6.55% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)GlobeNewswire
Documents & Filings
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.